Jack F V Hunt1, Nicholas M Vogt1, Erin M Jonaitis1, William R Buckingham1, Rebecca L Koscik1, Megan Zuelsdorff1, Lindsay R Clark1, Carey E Gleason1, Menggang Yu1, Ozioma Okonkwo1, Sterling C Johnson1, Sanjay Asthana1, Barbara B Bendlin2, Amy J H Kind2. 1. From the Wisconsin Alzheimer's Disease Research Center (J.F.V.H., N.M.V., M.Z., L.R.C., C.E.G., O.O., S.C.J., S.A., B.B.B., A.J.H.K.), Wisconsin Alzheimer's Institute (E.M.J., R.L.K., O.O., S.C.J., S.A., B.B.B.), Department of Medicine, Geriatrics Division (W.R.B., M.Z., L.R.C., C.E.G., O.O., S.C.J., S.A., B.B.B., A.J.H.K.), Health Services and Care Research Program (W.R.B., A.J.H.K.), and Department of Biostatistics & Medical Informatics (M.Y.), University of Wisconsin School of Medicine and Public Health; University of Wisconsin School of Nursing (M.Z.); and Geriatric Research Education and Clinical Center (GRECC) (L.R.C., C.E.G., O.O., S.C.J., S.A., B.B.B., A.J.H.K.), William S. Middleton Hospital, United States Department of Veterans Affairs, Madison, WI. 2. From the Wisconsin Alzheimer's Disease Research Center (J.F.V.H., N.M.V., M.Z., L.R.C., C.E.G., O.O., S.C.J., S.A., B.B.B., A.J.H.K.), Wisconsin Alzheimer's Institute (E.M.J., R.L.K., O.O., S.C.J., S.A., B.B.B.), Department of Medicine, Geriatrics Division (W.R.B., M.Z., L.R.C., C.E.G., O.O., S.C.J., S.A., B.B.B., A.J.H.K.), Health Services and Care Research Program (W.R.B., A.J.H.K.), and Department of Biostatistics & Medical Informatics (M.Y.), University of Wisconsin School of Medicine and Public Health; University of Wisconsin School of Nursing (M.Z.); and Geriatric Research Education and Clinical Center (GRECC) (L.R.C., C.E.G., O.O., S.C.J., S.A., B.B.B., A.J.H.K.), William S. Middleton Hospital, United States Department of Veterans Affairs, Madison, WI. ajk@medicine.wisc.edu bbb@medicine.wisc.edu.
Abstract
OBJECTIVE: To test the hypothesis that neighborhood-level disadvantage is associated with longitudinal measures of neurodegeneration and cognitive decline in an unimpaired cohort. METHODS: Longitudinal MRI and cognitive testing data were collected from 601 cognitively unimpaired participants in the Wisconsin Registry for Alzheimer's Prevention Study and the Wisconsin Alzheimer's Disease Research Center clinical cohort. Area Deprivation Index was geospatially determined based on participant residence geocode and ranked relative to state of residence. Linear regression models were fitted to test associations between neighborhood-level disadvantage and longitudinal change in cortical thickness and cognitive test performance. Mediation tests were used to assess whether neurodegeneration and cognitive decline were associated with neighborhood-level disadvantage along the same theoretical causal path. RESULTS: In our middle- to older-aged study population (mean baseline age 59 years), living in the 20% most disadvantaged neighborhoods (n = 19) relative to state of residence was associated with cortical thinning in Alzheimer signature regions (p = 0.002) and decline in the Preclinical Alzheimer's Disease Cognitive Composite (p = 0.04), particularly the Trail-Making Test, part B (p < 0.001), but not Rey Auditory Verbal Learning Test (p = 0.77) or Story Memory Delayed Recall (p = 0.49) subtests. Associations were attenuated but remained significant after controlling for racial and demographic differences between neighborhood-level disadvantage groups. Cortical thinning partially mediated the association between neighborhood-level disadvantage and cognitive decline. CONCLUSIONS: In this longitudinal study of cognitively unimpaired adults, living in the most highly disadvantaged neighborhoods was associated with accelerated degeneration in Alzheimer signature regions and cognitive decline. This study provides further evidence for neighborhood-level disadvantage as a risk factor for preclinical neurodegeneration and cognitive decline in certain populations. Limitations of the present study, including a small number of participants from highly disadvantaged neighborhoods and a circumscribed geographic setting, should be explored in larger and more diverse study cohorts.
OBJECTIVE: To test the hypothesis that neighborhood-level disadvantage is associated with longitudinal measures of neurodegeneration and cognitive decline in an unimpaired cohort. METHODS: Longitudinal MRI and cognitive testing data were collected from 601 cognitively unimpaired participants in the Wisconsin Registry for Alzheimer's Prevention Study and the Wisconsin Alzheimer's Disease Research Center clinical cohort. Area Deprivation Index was geospatially determined based on participant residence geocode and ranked relative to state of residence. Linear regression models were fitted to test associations between neighborhood-level disadvantage and longitudinal change in cortical thickness and cognitive test performance. Mediation tests were used to assess whether neurodegeneration and cognitive decline were associated with neighborhood-level disadvantage along the same theoretical causal path. RESULTS: In our middle- to older-aged study population (mean baseline age 59 years), living in the 20% most disadvantaged neighborhoods (n = 19) relative to state of residence was associated with cortical thinning in Alzheimer signature regions (p = 0.002) and decline in the Preclinical Alzheimer's Disease Cognitive Composite (p = 0.04), particularly the Trail-Making Test, part B (p < 0.001), but not Rey Auditory Verbal Learning Test (p = 0.77) or Story Memory Delayed Recall (p = 0.49) subtests. Associations were attenuated but remained significant after controlling for racial and demographic differences between neighborhood-level disadvantage groups. Cortical thinning partially mediated the association between neighborhood-level disadvantage and cognitive decline. CONCLUSIONS: In this longitudinal study of cognitively unimpaired adults, living in the most highly disadvantaged neighborhoods was associated with accelerated degeneration in Alzheimer signature regions and cognitive decline. This study provides further evidence for neighborhood-level disadvantage as a risk factor for preclinical neurodegeneration and cognitive decline in certain populations. Limitations of the present study, including a small number of participants from highly disadvantaged neighborhoods and a circumscribed geographic setting, should be explored in larger and more diverse study cohorts.
Authors: Philippa J Clarke; Jennifer A Ailshire; James S House; Jeffrey D Morenoff; Katherine King; Robert Melendez; Kenneth M Langa Journal: J Epidemiol Community Health Date: 2011-04-22 Impact factor: 3.710
Authors: Sarah E Monsell; Hiroko H Dodge; Xiao-Hua Zhou; Yunqi Bu; Lilah M Besser; Charles Mock; Stephen E Hawes; Walter A Kukull; Sandra Weintraub Journal: Alzheimer Dis Assoc Disord Date: 2016 Apr-Jun Impact factor: 2.703
Authors: Rahul S Desikan; Florent Ségonne; Bruce Fischl; Brian T Quinn; Bradford C Dickerson; Deborah Blacker; Randy L Buckner; Anders M Dale; R Paul Maguire; Bradley T Hyman; Marilyn S Albert; Ronald J Killiany Journal: Neuroimage Date: 2006-03-10 Impact factor: 6.556
Authors: Arleen F Brown; Li-Jung Liang; Stefanie D Vassar; Sharon Stein-Merkin; W T Longstreth; Bruce Ovbiagele; Tingjian Yan; José J Escarce Journal: Stroke Date: 2011-09-22 Impact factor: 7.914
Authors: Amy J H Kind; Steve Jencks; Jane Brock; Menggang Yu; Christie Bartels; William Ehlenbach; Caprice Greenberg; Maureen Smith Journal: Ann Intern Med Date: 2014-12-02 Impact factor: 25.391
Authors: Gavin Turrell; John W Lynch; George A Kaplan; Susan A Everson; Eeva-Liisa Helkala; Jussi Kauhanen; Jukka T Salonen Journal: J Gerontol B Psychol Sci Soc Sci Date: 2002-01 Impact factor: 4.077
Authors: Maragatha Kuchibhatla; Jaimie C Hunter; Brenda L Plassman; Michael W Lutz; Ramon Casanova; Santiago Saldana; Kathleen M Hayden Journal: Aging Ment Health Date: 2019-04-25 Impact factor: 3.658
Authors: Michael C Donohue; Reisa A Sperling; David P Salmon; Dorene M Rentz; Rema Raman; Ronald G Thomas; Michael Weiner; Paul S Aisen Journal: JAMA Neurol Date: 2014-08 Impact factor: 18.302
Authors: Sterling C Johnson; Rebecca L Koscik; Erin M Jonaitis; Lindsay R Clark; Kimberly D Mueller; Sara E Berman; Barbara B Bendlin; Corinne D Engelman; Ozioma C Okonkwo; Kirk J Hogan; Sanjay Asthana; Cynthia M Carlsson; Bruce P Hermann; Mark A Sager Journal: Alzheimers Dement (Amst) Date: 2017-12-08
Authors: Andrew P Merluzzi; Nicholas M Vogt; Derek Norton; Erin Jonaitis; Lindsay R Clark; Cynthia M Carlsson; Sterling C Johnson; Sanjay Asthana; Kaj Blennow; Henrik Zetterberg; Barbara B Bendlin Journal: Alzheimers Dement (N Y) Date: 2019-04-12
Authors: Taylor M Mobley; Crystal Shaw; Eleanor Hayes-Larson; Joseph Fong; Paola Gilsanz; Gilbert C Gee; Ron Brookmeyer; Rachel A Whitmer; Joan A Casey; Elizabeth Rose Mayeda Journal: Alzheimers Dement Date: 2022-04-06 Impact factor: 16.655
Authors: Miriam T Ashford; Rema Raman; Garrett Miller; Michael C Donohue; Ozioma C Okonkwo; Monica Rivera Mindt; Rachel L Nosheny; Godfrey A Coker; Ronald C Petersen; Paul S Aisen; Michael W Weiner Journal: Alzheimers Dement Date: 2022-02-25 Impact factor: 16.655
Authors: Neda Firouraghi; Behzad Kiani; Hossein Tabatabaei Jafari; Vincent Learnihan; Jose A Salinas-Perez; Ahmad Raeesi; MaryAnne Furst; Luis Salvador-Carulla; Nasser Bagheri Journal: Int J Health Geogr Date: 2022-08-04 Impact factor: 5.310
Authors: Matthew P Pase; Ella Rowsthorn; Marina G Cavuoto; Alexandra Lavale; Nawaf Yassi; Paul Maruff; Rachel F Buckley; Yen Ying Lim Journal: JAMA Netw Open Date: 2022-03-01